BioCorRx Inc.
BICX
$0.3859
$0.059918.37%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -82.68% | -84.58% | -77.66% | -58.37% | 5.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -82.68% | -84.58% | -77.66% | -58.37% | 5.88% |
| Cost of Revenue | -53.31% | -37.87% | 29.91% | 137.50% | 256.18% |
| Gross Profit | -90.21% | -91.22% | -88.88% | -73.16% | -10.32% |
| SG&A Expenses | 19.61% | -1.58% | -13.39% | -15.68% | -23.62% |
| Depreciation & Amortization | -0.74% | -1.47% | -2.19% | -2.90% | -2.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.89% | -5.63% | -22.07% | -22.05% | -14.70% |
| Operating Income | -17.49% | 1.14% | 19.24% | 20.40% | 15.32% |
| Income Before Tax | -24.95% | -6.42% | 10.02% | 13.85% | 10.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.95% | -6.42% | 10.02% | 13.85% | 10.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 590.48% | 167.61% | -56.41% | -52.00% | 31.25% |
| Net Income | -24.05% | -6.13% | 9.94% | 13.79% | 10.26% |
| EBIT | -17.49% | 1.14% | 19.24% | 20.40% | 15.32% |
| EBITDA | -17.60% | 1.14% | 19.35% | 20.50% | 15.39% |
| EPS Basic | -5.39% | 7.53% | 22.85% | 25.36% | 23.82% |
| Normalized Basic EPS | -14.79% | -4.30% | 15.70% | 20.30% | 29.91% |
| EPS Diluted | -5.44% | 7.46% | 22.68% | 25.20% | 23.67% |
| Normalized Diluted EPS | -14.79% | -4.30% | 15.70% | 20.30% | 29.91% |
| Average Basic Shares Outstanding | 16.46% | 13.98% | 16.16% | 15.90% | 16.56% |
| Average Diluted Shares Outstanding | 16.46% | 13.98% | 16.16% | 15.90% | 16.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
